Crude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Li, Wang ^a   Li, Yan ^a   Wang, Qing ^a   Yang, Yi ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EOSIN; FATTY ACID; GLUCOSE; HEMATOXYLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCIUM BARBARUM EXTRACT; LYCIUM BARBARUM POLYSACCHARIDE; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; POLYSACCHARIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY COMPOSITION; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENERGY CONSUMPTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL DIGESTIVE SYSTEM DISEASE; FATTY ACID BLOOD LEVEL; FATTY LIVER; GENE EXPRESSION PROFILING; GENE REPRESSION; GLUCOSE BLOOD LEVEL; HEPG2 CELL LINE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIPID STORAGE; LOW FAT DIET; LYCIUM BARBARUM; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; FATTY LIVER; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; MICE; PLANT EXTRACTS; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84903641342     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/196198     Document Type: Article

References (38)

1. Kim J.-A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance. Circulation Research 2008 102 4 401 414 2-s2.0-41949114990 10.1161/CIRCRESAHA.107.165472 (Pubitemid 351651099)
2. Chen J.-Q., Brown T. R., Russo J., Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochimica et Biophysica Acta: Molecular Cell Research 2009 1793 7 1128 1143 2-s2.0-67649398814 10.1016/j.bbamcr.2009.03.009
3. Fabbrini E., Sullivan S., Klein S., Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010 51 2 679 689 2-s2.0-75449094816 10.1002/hep.23280
4. Nagle C. A., Klett E. L., Coleman R. A., Hepatic triacylglycerol accumulation and insulin resistance. Journal of Lipid Research 2009 50 S74 S79 2-s2.0-66349088529 10.1194/jlr.R800053-JLR200
5. Raubenheimer P. J., Nyirenda M. J., Walker B. R., A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes 2006 55 7 2015 2020 2-s2.0-33747079056 10.2337/db06-0097 (Pubitemid 44509974)
6. Anderson N., Borlak J., Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacological Reviews 2008 60 3 311 357 2-s2.0-54049150442 10.1124/pr.108.00001
7. Asterholm I. W., Scherer P. E., Enhanced metabolic flexibility associated with elevated adiponectin levels. The American Journal of Pathology 2010 176 3 1364 1376 2-s2.0-77749242629 10.2353/ajpath.2010.090647
8. Qureshi K., Abrams G. A., Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2007 13 26 3540 3553 2-s2.0-34547460043 (Pubitemid 47162261)
9. Strable M. S., Ntambi J. M., Genetic control of de novo lipogenesis: role in diet-induced obesity. Critical Reviews in Biochemistry and Molecular Biology 2010 45 3 199 214 2-s2.0-77952863834 10.3109/10409231003667500
10. Li Y., Xu S., Mihaylova M. M., Zheng B., Hou X., Jiang B., Park O., Luo Z., Lefai E., Shyy J. Y.-J., Gao B., Wierzbicki M., Verbeuren T. J., Shaw R. J., Cohen R. A., Zang M., AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metabolism 2011 13 4 376 388 2-s2.0-79953755370 10.1016/j.cmet.2011.03.009
11. Luo Q., Cai Y., Yan J., Sun M., Corke H., Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sciences 2004 76 2 137 149 2-s2.0-7044271148 10.1016/j.lfs.2004.04.056 (Pubitemid 39425220)
12. Amagase H., Sun B., Borek C., Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults. Nutrition Research 2009 29 1 19 25 2-s2.0-58649100911 10.1016/j.nutres.2008.11.005
13. Lin C. L., Wang C. C., Chang S. C., Inbaraj B. S., Chen B. H., Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus. International Journal of Biological Macromolecules 2009 45 2 146 151 2-s2.0-67349263881 10.1016/j.ijbiomac.2009.04.014
14. Kleiner D. E., Brunt E. M., Van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y.-C., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J., Sanyal A. J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 41 6 1313 1321 2-s2.0-20044374023 10.1002/hep.20701 (Pubitemid 40770284)
15. Benhamed F., Denechaud P.-D., Lemoine M., Robichon C., Moldes M., Bertrand-Michel J., Ratziu V., Serfaty L., Housset C., Capeau J., Girard J., Guillou H., Postic C., The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. Journal of Clinical Investigation 2012 122 6 2176 2194 2-s2.0-84861809881 10.1172/JCI41636
16. Choi M.-S., Lee M.-K., Jung U. J., Kim H.-J., Do G.-M., Park Y. B., Jeon S.-M., Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet. Molecular Nutrition and Food Research 2009 53 6 751 759 2-s2.0-67651040885 10.1002/mnfr.200800241
17. Briand F., Thiéblemont Q., Muzotte E., Sulpice T., High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivomacrophage-to-feces reverse cholesterol transport in hamsters. Journal of Nutrition 2012 142 4 704 709 2-s2.0-84861174179 10.3945/jn.111. 153197
18. Matsuzaka T., Shimano H., Molecular mechanisms involved in hepatic steatosis and insulin resistance. Journal of Diabetes Investigation 2011 2 3 170 175 2-s2.0-79961089650 10.1111/j.2040-1124.2011.00111.x
19. Ferramosca A., Zara V., Modulation of hepatic steatosis by dietary fatty acids. World Journal of Gastroenterology 2014 20 7 1746 1755
20. Postic C., Girard J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. Journal of Clinical Investigation 2008 118 3 829 838 2-s2.0-40549135297 10.1172/JCI34275 (Pubitemid 351364588)
21. Anstee Q. M., Goldin R. D., Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. International Journal of Experimental Pathology 2006 87 1 1 16 2-s2.0-33644955272 10.1111/j.0959-9673.2006.00465.x
22. Park M.-Y., Mun S. T., Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice. Nutrition Research and Practice 2013 7 4 294 301 2-s2.0-84882666003 10.4162/nrp.2013.7.4.294
23. Zhou J., Zhai Y., Mu Y., Gong H., Uppal H., Toma D., Ren S., Evans R. M., Xie W., A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. Journal of Biological Chemistry 2006 281 21 15013 15020 2-s2.0-33744948052 10.1074/jbc.M511116200 (Pubitemid 43855205)
24. Stoeckman A. K., Towle H. C., The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. Journal of Biological Chemistry 2002 277 30 27029 27035 2-s2.0-0037178818 10.1074/jbc.M202638200 (Pubitemid 34951715)
25. Postic C., Girard J., The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes and Metabolism 2008 34 6 643 648 2-s2.0-62749188867 10.1016/S1262-3636(08)74599-3
26. Du R., Xue J., Wang H.-B., Zhang Y., Xie M.-L., Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. European Journal of Pharmacology 2011 666 1-3 183 188 2-s2.0-79960016926 10.1016/j.ejphar.2011. 05.014
27. Zhang C., Chen X., Zhu R.-M., Zhang Y., Yu T., Wang H., Zhao H., Zhao M., Ji Y.-L., Chen Y.-H., Meng X.-H., Wei W., Xu D.-X., Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicology Letters 2012 212 3 229 240 2-s2.0-84862984616 10.1016/j.toxlet.2012.06.002
28. Kohjima M., Higuchi N., Kato M., Kotoh K., Yoshimoto T., Fujino T., Yada M., Yada R., Harada N., Enjoji M., Takayanagi R., Nakamuta M., SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. International Journal of Molecular Medicine 2008 21 4 507 511 2-s2.0-44649111219 (Pubitemid 351802646)
29. Yap F., Craddock L., Yang J., Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. International Journal of Biological Sciences 2011 7 5 645 650 2-s2.0-79960131362
30. Park K.-G., Min A.-K., Koh E. H., Kim H. S., Kim M.-O., Park H.-S., Kim Y.-D., Yoo T.-S., Jang B. K., Hwang J. S., Kim J. B., Choi H.-S., Park J.-Y., Lee I.-K., Lee K.-U., Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008 48 5 1477 1486 2-s2.0-56149098763 10.1002/hep.22496
31. Jung E.-J., Kwon S.-W., Jung B.-H., Oh S.-H., Lee B.-H., Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver. Journal of Lipid Research 2011 52 9 1617 1625 2-s2.0-80051820360 10.1194/jlr.M015263
32. Vankoningsloo S., Piens M., Lecocq C., Gilson A., De Pauw A., Renard P., Demazy C., Houbion A., Raes M., Arnould T., Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid β -oxidation and glucose. Journal of Lipid Research 2005 46 6 1133 1149 2-s2.0-24944584210 10.1194/jlr.M400464-JLR200 (Pubitemid 43109829)
33. Santosa S., Jensen M. D., Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women. Diabetes 2013 62 3 775 782 2-s2.0-84874448989 10.2337/db12-0912
34. Yanagisawa R., Koike E., Win-Shwe T. T., Yamamoto M., Takano H., Impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet. Environmental Health Perspectives 2014 122 3 277 283
35. Horton J. D., Shimomura I., Ikemoto S., Bashmakov Y., Hammer R. E., Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. Journal of Biological Chemistry 2003 278 38 36652 36660 2-s2.0-0141704191 10.1074/jbc.M306540200 (Pubitemid 37139997)
36. Suqimoto S., Nakajima H., Kodo K., Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice. Nutrition and Metabolism 2014 11 1, article 14
37. Qian S.-W., Tang Y., Li X., Liu Y., Zhang Y.-Y., Huang H.-Y., Xue R.-D., Yu H.-Y., Guo L., Gao H.-D., Liu Y., Sun X., Li Y.-M., Jia W.-P., Tang Q.-Q., BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2013 110 9 E798 E807 2-s2.0-84874450879 10.1073/pnas.1215236110
38. Auffret J., Viengchareun S., Carré N., Denis R. G. P., Magnan C., Marie P.-Y., Muscat A., Fève B., Lombès M., Binart N., Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-dietinduced obesity. The FASEB Journal 2012 26 9 3728 3737 2-s2.0-84865781554 10.1096/fj.12-204958